Capital Fund Management (CFM)
ANAB icon

Capital Fund Management (CFM)’s AnaptysBio ANAB Stock Holding History

Capital Fund Management (CFM)’s Portfolio ANAB Stock Details ANAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-16,526
Closed -$234K – 1014
2020
Q1 		$234K Buy
+16,526
New +$251K ﹤0.01% 1334
2019
Q1 		– Sell
-8,600
Closed -$549K – 1645
2018
Q4 		$549K Buy
+8,600
New +$640K ﹤0.01% 1335

Other funds holding ANAB

EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
FM
Frazier Management Seattle, Washington $1.12M AUM 151.58% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ACM
Aquilo Capital Management San Francisco, California $55.8M AUM 41.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

Capital Fund Management (CFM)'s ANAB Position: Q2 2020 in Review

Capital Fund Management (CFM) sold out of AnaptysBio (ANAB) in Q2 2020, closing a stake of 16,526 shares — an estimated $234K sold.

Capital Fund Management (CFM) first reported a position in ANAB in Q4 2018 and held it in 2 quarters. The position peaked at $549K in Q4 2018. 122 funds tracked by Wall St. Rank hold ANAB as of Q2 2020.

  • Capital Fund Management (CFM) reported no remaining AnaptysBio position as of Q2 2020 after selling out during the quarter.
  • Capital Fund Management (CFM) sold 16,526 AnaptysBio shares in Q2 2020, an estimated $234K.
  • Capital Fund Management (CFM) first reported a position in AnaptysBio in Q4 2018 and held it in 2 quarters.
  • Capital Fund Management (CFM)'s AnaptysBio position peaked at $549K in Q4 2018.
  • 122 funds tracked by Wall St. Rank held AnaptysBio as of Q2 2020.

Based on Capital Fund Management (CFM)'s 13F filing for Q2 2020, filed 13 Aug 2020.